Full Text
Budget Impact of Etanercept Versus Adalimumab for Treatment of Rheumatoid Arthritis In Biologic-Naïve Patients in the United Kingdom

Abstract

Authors

K Onishchenko M Tarallo C Curiale ST Alexopoulos

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×